The BMTF aims to provide an environment in which the existing research expertise from partners and collaborators will come together to create critical mass in collaborative multidisciplinary research teams, to develop new materials for devices, diagnostics, delivery technologies, imaging agents and the assessment of these materials through new, non-invasive, in situ imaging techniques.
Two biological isolator facilities have been established to facilitate clinical development of human cell-based therapies. Established under the auspices of the Victorian Consortium for Cell-based Therapies (VCCT), the isolators provide a complete barrier from environmental and operator-borne contamination and are therefore ideally suited for aseptic processing.
The Melbourne Centre for Nanofabrication (MCN) provides open-access to cutting-edge micro-nano fabrication instrumentation in a world-class facility. With twelve highly experienced technical staff devoted to R&D partnerships with industry and a wide range of instrumentation in the one facility, we enable productivity and quality gains for researchers and innovators.